|
CorrectCare
Legal Affairs
Forced
Psychotropics: The Sell v. USA Case
By Shelley R. Stanton, MD, and Daryl Kosiak, JD
Does the government’s interest in bringing a defendant
accused of a nonviolent crime to trial outweigh the liberty
interest of the defendant to avoid unwanted medication? This
was the question before the Supreme Court in Sell v. USA.
Unfortunately, the majority opinion, issued in June 2003, is
complex and open to further interpretation.
Let’s review the facts of the case. Dr.
Sell is a 52-year-old, twice-married, white, male dentist
charged with 56 counts of mail fraud, six counts of Medicaid
fraud, one count of money laundering and two counts of
conspiracy to commit murder and witness tampering. He was
initially arrested in 1997 on the fraud charges and released
on bond. In 1998 bond was revoked because of the new charges,
and since then he has been incarcerated primarily in the
Medical Center for Federal Prisoners at Springfield, MO.
The clinical history revealed that Dr.
Sell has a 21-year history of intermittent contact with mental
health professionals, most often related to pronounced
paranoid delusions, some olfactory, auditory and visual
hallucinations, and bizarre behavior related to these
psychotic experiences.
While in custody, Dr. Sell had two
competency evaluations by the government and two by a
psychiatrist hired by the defense. He was found incompetent in
the last three of the four evaluations, with diagnoses as
follows:
Axis I: Delusional disorder, persecutory
type (plus major depressive disorder, recurrent, by private
psychiatrist)
Axis II: Personality disorder (paranoid, or borderline with
prominent paranoid features)
The mental health professionals opined
that mental illness has rendered Dr. Sell unable to assist his
attorney in his own defense and that he does not have a
rational and factual understanding of the crime with which he
is charged.
The court found that Dr. Sell is
incompetent to stand trial and ordered him into the custody of
the attorney general for the purpose of hospitalization and
treatment to restore him to competence.
The attending psychiatrist determined
that antipsychotic medication is the only treatment by which
the defendant is likely to be restored to competence. However,
Dr. Sell appealed that clinical finding and has refused
voluntary treatment.
An administrative due process hearing was
held and involuntary medication was determined to be medically
appropriate and necessary for restoration of competence.
Before the defendant was involuntary
medicated, he filed an appeal that over four years made its
way through the lower courts, all of them finding in favor of
the government. On March 3, 2003, the case was argued before
the Supreme Court.
Legal Guidance
This case involves multiple legal, medical and ethical
dilemmas. Some guidance may be found in federal statutes that
govern the evaluation, treatment and confinement of defendants
with possible mental illness (see Title 18, US Code, §4241-4247).
Bottom line: All individuals committed to the custody of the
attorney general for mental health evaluation or treatment are
still accorded due process prior to the administration of
involuntary medication.
In addition, the legal background in
which any particular case is viewed is based on preceding
cases, regardless of the time that has passed since those
cases were settled and regardless of how science, society or
any other factors may have changed.
Over the last 30 years, case law (see Washington
v. Harper, Riggins v. Nevada, US v. Brandon
and US v. Weston) has established that for the
government to involuntary medicate an individual, it must show
three things:
1. There is an essential government
interest that outweighs the individual’s liberty interest in
remaining free of unwanted intrusions (medication).
2. There is no less restrictive or intrusive means to achieve
the government’s interest.
3. Medication is medically appropriate for the individual’s
condition.
The Defendant’s Argument
The defendant contends that administration of “medication
against his will solely to render him competent to stand trial
for nonviolent offenses would violate his rights under the
First, Fifth and Sixth Amendments.”
Six amicus briefs were filed on behalf of
the defendant. Some excerpts:
“...the rights to liberty, bodily integrity, freedom of
thought and privacy are fundamental rights....”
“Dr. Sell has fundamental trial rights...not to be medicated
into drug-induced, synthetic sanity.... In a case where
diminished capacity is raised as a defense, the jury must
assess their belief about the defendant’s mental state at
the time the crime occurred.... The accused, sitting in the
courtroom drugged and listless, becomes an instrument of his
own conviction....”
The defendant’s side also argued that
“[a]ntipsychotic medications are potent, mind-altering drugs
with the potential for severe, irreversible, and even deadly
side effects.... They] do not cure illnesses; they simply
suppress symptoms....” He further argues that the government
wants to medicate Dr. Sell only so that it can bring him to
trial.
An amicus brief from the American
Psychological Association repeats the defendant’s
constitutional arguments, but also provides a more balanced
look at the issue of antipsychotic medication. It mentions
that antipsychotics are very effective, and even while
espousing the benefits of nondrug therapies it notes that they
are not likely to be effective in Dr. Sell’s case.
The Government’s Argument
To summarize the government’s argument, it said that it has
a compelling interest in adjudicating serious criminal
charges, but since an incompetent defendant cannot be brought
to trial, the government has an essential interest in making
efforts to restore competence.
The government emphasized the devastating
effects of untreated psychosis and noted the ability to manage
side effects of antipsychotics through dosage changes,
medication changes or the addition of other medications to
treat side effects.
The government also argued that the
impact of medication on the defendant’s right to a fair
trial can be determined only after the treatment, not before.
Further, the defendant does not have a right to appear before
the court in the same state of mind that he was in before
commission of the crime.
An amicus brief from the American
Psychiatric Association aimed in part to “ensure that the
court has well-grounded facts about antipsychotic
medications...and appreciates the adverse consequences...of
not giving ...the medically appropriate treatment for
psychotic illnesses....”
The Court’s Decision
An argument before the Supreme Court is a relatively civilized
(though adversarial), much rehearsed and painfully abbreviated
presentation of exceedingly complex social, legal and moral
issues. And the decision has the potential to have profound,
far-reaching, long-term ramifications.
In Sell v. USA, the Supreme
Court’s holding is as follows: The government may
involuntary medicate a nondangerous pretrial detainee solely
for the purpose of restoring to competency to stand trial
when...
1. The
treatment is medically appropriate (that is, in the
patient’s best medical interest).
2. It is proven that the
treatment is substantially likely to restore competency, and
that it is substantially unlikely to have side effects that
would undermine the fairness of the criminal trial.
3. Compared to less
intrusive means, the treatment furthers an important
government interest, considering factors such as the
seriousness of the alleged crime and any special circumstances
that lessen the importance of the government interest.
The dissenting opinion of three justices
strongly stated that since this case involved an interlocutory
order (an interim order that decides only a part of the case
without necessarily deciding the entire litigation),
the Court of Appeals and the Supreme Court do not have
jurisdiction until after adjudication of the criminal case by
the lower court.
In light of the Supreme Court decision,
the government will have to again bring the issue of
involuntary medication before the lower court. If it is
eventually determined that one or more of the above conditions
are not met, then the government has several options:
• It can pursue its responsibility
under §4246 to evaluate Dr. Sell for dangerousness, which is
likely to result in his indefinite commitment to the Bureau of
Prisons. It can later pursue adjudication of the fraud charges
if he ever recovers to the extent that he becomes competent to
stand trial.
• It can pursue the conspiracy to
commit murder charges. Under these charges, it is likely that
the government would meet the compelling interest necessary to
involuntarily medicate Dr. Sell and bring him to trial.
While the outcome of the trial cannot be
predicted, typically the presence of a delusional disorder
does not preclude an individual from having the capacity to
understand the wrongfulness of his actions or the ability to
conform his actions. If that were to be found in ths case, he
could be found guilty. Upon expiration of his sentence he
would likely still be mentally ill and may satisfy the
criteria for commitment under §4246.
— About the authors:
Shelley R. Stanton, MD, and Daryl Kosiak, JD,
work for the Federal Bureau of Prisons; Stanton is chief
psychiatrist based in Washington, DC, and Kosiak is counsel
for the North Central Region, Kansas City, KS. E-mail Stanton
at sstanton@bop.gov. To find the statutes discussed above,
visit the Web at www.gpoaccess.gov/cfr/index.html.
[This article first appeared in the
Fall 2003 issue of
CorrectCare.]
|